10 research outputs found
Phenolische Desinfektionsmittel mit mehreren halogenierten Benzolkernen
Phenolische Desinfektionsmittel mit mehreren (in der Regel zwei) halogenierten Benzolkernen sind heute in weitem Umfang an die Stelle der einfachen Phenole und deren Abkömmlinge getreten. Man findet sie in zahlreichen Produkten der Desinfektions‐, Körperpflege‐ und Reinigungsmittelindustrie. Die vorliegende Zusammenstellung beschäftigt sich mit der Synthese sowie dem Zusammenhang zwischen Wirkung gegen Mikroorganismen und der Konstitution dieser Körper. Sie zeigt weiter die Vielfalt der unter dem Thema zu nennenden Verbindungen
Learning, reflexivity, decision-making, and behavioral change for sustainable viticulture associated with participatory action research
Abstract Despite the abundance of compelling scientific knowledge about dramatic changes in climate, biodiversity and the environment, there is little change in human behavior. Do humans perceive and understand the gravity of the challenges at stake, or are they overwhelmed by adversity? The challenge may be in finding appropriate levers to involve stakeholders in a broader process of shared learning, while producing scientific knowledge, to overcome uncertainty, and achieving the expected collective action? In the field of viticulture, researchers, winegrowers, citizens and environmental associations have been involved in participatory action research projects, one located in Switzerland, one in Germany and two in France. All actors were involved, from the formulation of questions up to the production of knowledge, to address the issue of the negative impacts of viticulture on the environment and human health. Group workshops and individual interviews were conducted on each of the four sites, for a nine-year period. A collective workshop involving also actors outside the project was conducted, and followed by a trinational workshop bringing together actors from Swiss, German and French projects. The audio recordings and writings produced were transcribed. All texts were analyzed on the linguistic level, with textometric tools, while going back to the actors’ initial quotes. Our results suggest that during the course of projects, more sustainable viticultural practices were designed, and implemented in the vineyard, on a large scale. Also, our analysis suggests that, in parallel to changes in viticulture practices, a new vocabulary, associated with different individual and collective reasoning, emerged in the discourse of the actors involved in projects. These major changes were associated with an inventiveness that developed within and beyond the groups. Because human reasoning changed in the context of participatory action research, we suggest that such a research format could address global issues, finally reaching awaited changes
Intravenous NPA for the treatment of infarcting myocardium early: InTIME-II, a double-blind comparison on of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction
Aims to compare the efficacy and safety of lanoteplase, a single-bolus thrombolytic drug derived from alteplase tissue plasminogen activator, with the established accelerated alteplase regimen in patients presenting within 6 h of onset of ST elevation acute myocardial infarction. Methods and Results 15 078 patients were recruited from 855 hospitals worldwide and randomized in a 2:1 ratio to receive either lanoteplase 120 KU. kg-1 as a single intravenous bolus, or up to 100 mg accelerated alteplase given over 90 min. The primary end-point was all-cause mortality at 30 days and the hypothesis was that the two treatments would be equivalent. By 30 days, 6.61% of alteplase-treated patients and 6.75% lanoteplase-treated patients had died (relative risk 1.02). Total stroke occurred in 1.53% alteplase- and 1.87% lanoteplase-treated patients (ns); haemorrhagic stroke rates were 0.64% alteplase and 1.12% lanoteplase (P=0.004). The net clinical deficit of 30-day death or non-fatal disabling stroke was 7.0% and 7.2%, respectively. By 6 months, 8.8% of alteplase-treated patients and 8.7% of lanoteplase-treated patients had died. Conclusion Single-bolus weight-adjusted lanoteplase is an effective thrombolytic agent, equivalent to alteplase in terms of its impact on survival and with a comparable risk-benefit profile. The single-bolus regimen should shorten symptoms to treatment times and be especially convenient for emergency department or out-of-hospital administration. (C) 2000 The European Society of Cardiology